Hu A, Kotze PG, Burgevin A, Tan W, et al. Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or Ustekinumab. Clin Gastroenterol Hepatol 2021;19:1366-1376.
PMID: 32668338